Urinary Incontinence Products Sales

Urinary Incontinence Products Sales Market Outlook

The global urinary incontinence products sales market is estimated to reach approximately USD 5.2 billion by 2035, growing at a compound annual growth rate (CAGR) of around 6.5% from 2025 to 2035. The rising prevalence of urinary incontinence, coupled with an aging population and increasing awareness about available treatment options, significantly contribute to the market's growth. Additionally, innovations in product design, such as the development of more comfortable and discreet absorbent products, are expected to drive demand. The growing focus on improving the quality of life for patients and advancements in healthcare technologies are also vital factors propelling market expansion. Furthermore, increased healthcare expenditure across various regions is anticipated to provide a consistent boost to sales in the urinary incontinence products market.

Growth Factor of the Market

One of the most significant growth factors for the urinary incontinence products market is the increasing incidence of urinary incontinence among both men and women, driven by various health issues such as obesity, diabetes, and neurological disorders. The expanding geriatric population is particularly noteworthy, as older adults are at a higher risk of experiencing incontinence. Moreover, enhanced awareness about available products, including absorbent pads and surgical options, encourages more individuals to seek treatment, thus driving market growth. The expansion of healthcare facilities, especially in emerging economies, further supports the market as they adopt advanced incontinence management solutions. Finally, the shift towards online platforms for purchasing these products has increased accessibility for consumers, making it easier for them to find suitable options tailored to their needs.

Key Highlights of the Market

• Growing prevalence of urinary incontinence and related health conditions.
• Innovation in product design enhances comfort and discretion.
• Increasing healthcare expenditure supports market growth.
• Expansion of online distribution channels improves product accessibility.
• Focus on improving quality of life drives demand for incontinence solutions.

By Product Type

Internal Devices :

Internal devices are a critical segment of the urinary incontinence products market, encompassing various solutions designed to be inserted into the body to provide support or control over involuntary urination. These devices include bladder stimulators and inflatable penile prostheses, aimed primarily at individuals with more severe cases of incontinence. The adoption of these products is on the rise due to their effectiveness in improving urinary control and the growing acceptance of surgical interventions. Additionally, advancements in medical technology have led to the development of less invasive internal devices, enhancing patient comfort and recovery time. The increasing number of healthcare professionals trained in these procedures further supports the growth of this product type within the market.

External Devices :

External devices are widely used in the management of urinary incontinence, primarily designed for patients who experience moderate to mild symptoms. This category includes external catheters and penile clamps, which offer a non-invasive alternative for managing leakage. These products have gained popularity due to their ease of use and the ability to maintain a degree of independence for users, especially in homecare settings. Furthermore, the growing trend towards home-based healthcare solutions is driving demand for external devices, as patients seek convenient management options without the need for frequent hospital visits. As manufacturers continue to innovate with materials and designs that improve user comfort, the external devices segment is poised for sustained growth in the coming years.

Medications :

Medications form a significant segment of the urinary incontinence products market, encompassing various pharmaceutical solutions aimed at alleviating symptoms of incontinence. These may include anticholinergic drugs, beta-3 adrenergic agonists, and topical estrogen, which work by relaxing the bladder or improving bladder capacity. The segment is expected to grow steadily as more healthcare professionals recognize the efficacy of pharmacological treatments in managing urinary incontinence. Moreover, increased research and development efforts are likely to introduce new medications into the market, expanding therapeutic options for patients. Education and awareness campaigns about available treatments will also play a crucial role in encouraging individuals to seek medical help, thereby boosting the medications segment.

Absorbent Products :

Absorbent products, including adult diapers, pads, and liners, are among the most widely used solutions for managing urinary incontinence, catering to various levels of severity. The high demand for these products is largely driven by a growing aging population that increasingly requires effective incontinence solutions. The absorbent products segment is characterized by continuous innovation, with manufacturers focused on improving absorbency, comfort, and discretion. The introduction of products that incorporate odor-control technologies and skin-friendly materials is further enhancing consumer appeal. With ongoing marketing efforts highlighting the benefits of absorbent products, coupled with their availability through various distribution channels, this segment is expected to experience substantial growth over the forecast period.

Surgical Devices :

Surgical devices represent a critical aspect of the urinary incontinence products market, primarily targeting patients with severe cases that do not respond to conservative management. This category includes sling procedures, artificial urinary sphincters, and bladder neck suspension techniques, aimed to provide long-term relief from incontinence. The demand for surgical solutions is on the rise, driven by advancements in surgical techniques and technology, which have improved the success rates and recovery times associated with these procedures. Additionally, the increasing number of healthcare facilities offering specialized urology services contributes to the segment's growth. Patients are increasingly seeking more permanent solutions for urinary incontinence, thus bolstering the market for surgical devices.

By Application

Hospitals :

Hospitals play a pivotal role in the urinary incontinence products market, as they are often the first point of contact for patients seeking treatment. Healthcare professionals in hospitals are equipped to perform diagnostic assessments and offer a range of incontinence management solutions, including surgical interventions and referrals to specialized clinics. The presence of comprehensive care teams, including urologists, nurses, and physiotherapists, enhances patient education and the adoption of appropriate products. Furthermore, hospitals are increasingly investing in advanced technologies and equipment to improve patient outcomes in managing urinary incontinence, which is anticipated to drive demand for incontinence products within this setting.

Homecare Settings :

Homecare settings represent a growing application segment for urinary incontinence products, as patients increasingly prefer to manage their conditions in the comfort of their homes. The shift towards home healthcare solutions is influenced by factors such as aging populations and advancements in telemedicine, which facilitate remote consultations with healthcare providers. This trend has led to an increased demand for absorbent products and external devices that can be easily used in a home environment. Additionally, the growing awareness of incontinence management options among caregivers and family members is driving the uptake of these products in homecare settings, contributing to the overall growth of this segment.

Nursing Homes :

Nursing homes serve as essential facilities for individuals with chronic conditions, including urinary incontinence, necessitating efficient management solutions. The concentrated demographic of older adults in nursing homes creates a significant demand for a range of urinary incontinence products, particularly absorbent items and medications. Staff training programs on incontinence management are vital in ensuring the proper use of these products, ultimately enhancing the quality of care provided to residents. Furthermore, the implementation of tailored care plans for individuals with incontinence issues is driving the growth of this segment, as more nursing homes adopt specialized training to better address the needs of their residents.

Other Facilities :

Other facilities, including rehabilitation centers and assisted living communities, also play a role in the urinary incontinence products market. These facilities often cater to a diverse population of individuals who may experience varying degrees of incontinence, necessitating a broad range of product offerings. The focus on patient-centered care within these environments fosters an increased awareness of incontinence management strategies, driving demand for absorbent products and medications. Additionally, the growing trend towards providing personalized care plans in these facilities enhances the quality of life for residents, further contributing to the market's growth. Continued investment in staff training and education on urinary incontinence will also help bolster the demand for products in this segment.

By Distribution Channel

Retail Pharmacies :

Retail pharmacies serve as a significant distribution channel for urinary incontinence products, providing consumers with easy access to a variety of solutions. The convenience of purchasing these products at local pharmacies encourages individuals to seek management options with discretion. Retail pharmacies often carry a diverse range of absorbent products, medications, and external devices, catering to the needs of different consumer segments. Additionally, the presence of knowledgeable pharmacists aids customers in selecting the appropriate products based on their specific conditions. The growing trend of pharmacies offering private consultation areas for sensitive discussions about incontinence further enhances the shopping experience for consumers, driving sales through this channel.

Online Stores :

Online stores have emerged as a highly effective distribution channel for urinary incontinence products, offering consumers the convenience of home delivery and broad product selection. E-commerce platforms enable users to discreetly shop for a variety of incontinence solutions while benefiting from customer reviews and recommendations. The growing reliance on online shopping, accelerated by the COVID-19 pandemic, has significantly boosted sales in this segment. Furthermore, many online retailers provide subscription services for frequently used products, enhancing customer loyalty and ensuring consistent availability. The ease of comparing prices and products online empowers consumers to make informed purchasing decisions, further propelling the growth of online stores in the urinary incontinence products market.

Hospitals & Clinics :

Hospitals and clinics are integral distribution channels for urinary incontinence products, as they provide direct access to specialized medical care and incontinence management solutions. In these settings, healthcare professionals can prescribe appropriate products based on individual patient needs, ensuring a tailored approach to management. The collaboration between product manufacturers and medical facilities often leads to the availability of the latest incontinence products, enhancing patient outcomes. Additionally, the convenience of obtaining necessary supplies during medical consultations fosters a seamless experience for patients. As the healthcare landscape evolves, hospitals and clinics will continue to play a crucial role in the distribution of urinary incontinence products.

Others :

The "Others" distribution channel encompasses various alternative avenues for purchasing urinary incontinence products, including direct-to-consumer sales and specialty health stores. These channels cater to niche markets, often providing unique or specialized products not found in traditional retail settings. Direct-to-consumer models allow manufacturers to engage with customers, enhancing brand loyalty and facilitating feedback. Specialty health stores may offer expert advice on product selection tailored to specific needs, appealing to consumers seeking personalized solutions. The growing interest in holistic health approaches also drives demand for natural or eco-friendly incontinence products available through these channels, further diversifying the market landscape.

By Material Type

Silicone :

Silicone is a popular material used in the production of various urinary incontinence products, particularly in internal devices and external catheters. Known for its flexibility and biocompatibility, silicone ensures a comfortable fit for users while minimizing the risk of irritation or allergic reactions. The inherent durability of silicone products allows them to maintain their performance over time, making them a preferred choice for patients requiring long-term management solutions. Additionally, advancements in silicone technology have led to the development of products with enhanced properties, such as improved absorbency and odor control. As awareness of the benefits of silicone-based products grows, their use in the urinary incontinence market is expected to increase significantly.

Latex :

Latex is another widely used material in urinary incontinence products, particularly in external devices and absorbent products. Its natural elasticity provides a snug fit, which is essential for effective leakage management. However, the growing awareness of latex allergies has prompted manufacturers to explore alternative materials, thereby influencing market dynamics. Despite this challenge, latex products remain popular due to their affordability and efficacy. Continuous innovations in latex formulations are aimed at enhancing comfort and minimizing allergic reactions. As more consumers seek effective solutions for urinary incontinence, the latex segment is poised for sustained demand, although careful consideration of allergy concerns will remain a priority.

Polyethylene :

Polyethylene is commonly utilized in the production of absorbent products, offering excellent moisture retention and skin protection for individuals managing urinary incontinence. The lightweight nature of polyethylene enhances user comfort and ease of use, making these products suitable for individuals across various demographics. The versatility of polyethylene allows manufacturers to develop a wide range of products, from adult diapers to liners, catering to different levels of incontinence severity. As consumer preferences shift towards higher-quality absorbent products, the polyethylene segment is expected to experience continued growth, driven by innovations that improve performance and user satisfaction.

Rubber :

Rubber is utilized in some external devices and surgical products, providing flexibility and durability essential for effective incontinence management. Its elastic properties allow for a comfortable fit while maintaining the necessary support for users. However, similar to latex, rubber products may pose allergenic risks for certain individuals, leading to a cautious approach in their adoption. Manufacturers are increasingly focusing on creating hypoallergenic rubber formulations to mitigate these concerns. As healthcare providers seek reliable solutions for patients with severe incontinence, the rubber segment is expected to sustain its relevance in the market, particularly in surgical applications.

Others :

The "Others" material segment encompasses various alternative materials used in urinary incontinence products, including biodegradable options and advanced composites designed for optimal performance. The trend towards eco-friendly products is gaining traction, driven by rising consumer awareness of sustainability and environmental impact. Manufacturers are increasingly experimenting with innovative materials that offer similar or superior performance to traditional options, catering to the growing demand for sustainable incontinence management solutions. As regulatory pressures surrounding environmental issues intensify, the development and adoption of alternative materials in the urinary incontinence products market are expected to gain momentum, further diversifying the product landscape.

By Region

The urinary incontinence products market exhibits distinct regional dynamics, with North America and Europe leading in market share due to their advanced healthcare infrastructure and high prevalence rates of urinary incontinence. In North America, the market was valued at approximately USD 2.1 billion in 2023, representing a significant portion of the global market. This growth is driven by the increasing aging population, high healthcare spending, and the growing acceptance of incontinence management products. Moreover, the North American market is expected to witness a CAGR of 7% during the forecast period, as innovative products and telemedicine solutions continue to emerge as viable management options. Europe follows closely, with a market value of around USD 1.6 billion, where factors such as increased awareness and government support for healthcare initiatives are contributing to market expansion.

In the Asia Pacific region, the urinary incontinence products market is experiencing robust growth, projected to reach approximately USD 1.2 billion by 2035, with a CAGR of 8.5%. The rising prevalence of urinary incontinence, particularly among the elderly population, is a critical driver of this growth. Additionally, increased healthcare investments and the expansion of distribution channels in emerging economies such as India and China are facilitating greater access to incontinence products. Meanwhile, Latin America and the Middle East & Africa are anticipated to witness steady growth, with market values projected at USD 400 million and USD 300 million respectively by 2035, driven by growing awareness and the adoption of modern healthcare solutions.

Opportunities

The urinary incontinence products market presents numerous opportunities for growth, particularly driven by advancements in technology and consumer-focused innovations. The increasing emphasis on product development, including the introduction of smart incontinence products equipped with monitoring capabilities, offers significant potential. These technologies not only provide real-time data on bladder activity but also assist healthcare providers in customizing treatment plans for patients. Additionally, the integration of telemedicine in managing urinary incontinence is an emerging opportunity, allowing patients to receive support and consultations from healthcare professionals without the need for in-person visits. This shift towards personalized and remote care solutions positions the market favorably for sustained growth.

Furthermore, the growing consumer preference for sustainable and eco-friendly products is shaping the future of the urinary incontinence market. Manufacturers who invest in the production of biodegradable and low-impact materials will likely capture a growing share of the market, appealing to environmentally conscious consumers. The expansion of e-commerce platforms is also a significant opportunity, as it enhances product accessibility and enables targeted marketing strategies to reach specific demographics. Targeting niche markets, such as male incontinence products or solutions for athletes, can further drive growth by addressing unmet needs within the urinary incontinence landscape.

Threats

Despite the positive outlook for the urinary incontinence products market, several threats could impede growth. One considerable challenge is the increasing competition from alternative incontinence management solutions, such as pelvic floor exercises and alternative therapies. These approaches are gaining popularity among consumers seeking non-invasive treatments, potentially affecting the demand for traditional incontinence products. Additionally, the prevalence of counterfeit products in the market poses a significant risk, as consumers may unknowingly purchase substandard or ineffective solutions, leading to decreased trust in the overall product category. This situation necessitates continuous education and awareness efforts to ensure consumers choose reputable products that meet their needs.

Moreover, regulatory challenges and compliance with stringent safety standards can hinder market growth, particularly for new entrants. As manufacturers navigate the complexities of product approvals and quality assurance, the associated costs and timeframes may discourage innovation. Lastly, fluctuating economic conditions may impact consumer spending on discretionary health products, with individuals prioritizing essential healthcare needs over incontinence management solutions. Consequently, addressing these threats will be vital for stakeholders in the urinary incontinence products market to sustain long-term growth.

Competitor Outlook

• Procter & Gamble Co.
• Kimberly-Clark Corporation
• Coloplast A/S
• Essity AB
• Hollister Incorporated
• Medtronic plc
• Boston Scientific Corporation
• Unicharm Corporation
• ConvaTec Group plc
• Attends Healthcare Products, Inc.
• SCA Hygiene Products AB
• Ontex Group NV
• First Quality Enterprises, Inc.
• Insider Technologies
• Farlin Corporation

Overall, the competitive landscape of the urinary incontinence products market is characterized by a mix of established players and new entrants, each vying to capture a share of this growing sector. Major companies such as Procter & Gamble and Kimberly-Clark dominate the market, leveraging their extensive distribution networks and brand recognition to offer a diverse range of incontinence products. These industry leaders invest heavily in research and development to innovate continuously, resulting in the development of advanced products that address consumer needs. Furthermore, partnerships and collaborations between companies and healthcare providers are increasingly common, aimed at enhancing product offerings and ensuring better outcomes for patients.

Coloplast, Essity, and Hollister are also prominent competitors in the urinary incontinence products market, focusing on providing specialized solutions tailored to different demographics. Coloplast, for instance, offers a wide range of external catheters and absorbent products designed to meet the needs of both male and female patients. Meanwhile, Essity emphasizes sustainability in its product offerings, appealing to environmentally conscious consumers. As competition intensifies, companies are likely to enhance their marketing strategies, targeting specific consumer segments and leveraging digital platforms to engage customers effectively.

In addition to these established players, a growing number of startups and smaller companies are entering the market with innovative solutions aimed at addressing gaps in the urinary incontinence landscape. These new entrants often focus on developing niche products, such as disposable undergarments for younger adults or specialized absorbent products for athletes. By catering to specific consumer needs, these companies can differentiate themselves in a competitive environment. As the urinary incontinence products market continues to evolve, the interplay between established firms and new innovators will shape the future landscape, driving continued growth and improving the quality of products available to consumers.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Essity AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Coloplast A/S
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Ontex Group NV
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 ConvaTec Group plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Farlin Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Insider Technologies
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Procter & Gamble Co.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Unicharm Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Hollister Incorporated
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 SCA Hygiene Products AB
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Kimberly-Clark Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 First Quality Enterprises, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Attends Healthcare Products, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Urinary Incontinence Products Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Homecare Settings
    • 6.1.3 Nursing Homes
    • 6.1.4 Other Facilities
  • 6.2 Urinary Incontinence Products Sales Market, By Product Type
    • 6.2.1 Internal Devices
    • 6.2.2 External Devices
    • 6.2.3 Medications
    • 6.2.4 Absorbent Products
    • 6.2.5 Surgical Devices
  • 6.3 Urinary Incontinence Products Sales Market, By Material Type
    • 6.3.1 Silicone
    • 6.3.2 Latex
    • 6.3.3 Polyethylene
    • 6.3.4 Rubber
    • 6.3.5 Others
  • 6.4 Urinary Incontinence Products Sales Market, By Distribution Channel
    • 6.4.1 Retail Pharmacies
    • 6.4.2 Online Stores
    • 6.4.3 Hospitals & Clinics
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Urinary Incontinence Products Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Urinary Incontinence Products Sales market is categorized based on

By Product Type

• Internal Devices
• External Devices
• Medications
• Absorbent Products
• Surgical Devices

By Application

• Hospitals
• Homecare Settings
• Nursing Homes
• Other Facilities

By Distribution Channel

• Retail Pharmacies
• Online Stores
• Hospitals & Clinics
• Others

By Material Type

• Silicone
• Latex
• Polyethylene
• Rubber
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Procter & Gamble Co.
• Kimberly-Clark Corporation
• Coloplast A/S
• Essity AB
• Hollister Incorporated
• Medtronic plc
• Boston Scientific Corporation
• Unicharm Corporation
• ConvaTec Group plc
• Attends Healthcare Products, Inc.
• SCA Hygiene Products AB
• Ontex Group NV
• First Quality Enterprises, Inc.
• Insider Technologies
• Farlin Corporation